Watchlist

Watchlist
Amedisys Inc (AMED)
Amedisys' (AMED) CEO Paul Kusserow on Q1 2018 Results - Earnings Call Transcript
Amedisys, Inc. (AMED) Q1 2018 Earnings Conference Call May 8, 2018 11:00 am ET Executives Nicholas Muscato - Chief Of Staff Paul Kusserow - President and CEO Scott Ginn - CFO Chris Gerard - COO David Kemmerly - General Counsel and SVP of Government Affairs Susan Sender - SV…
AMEDISYS Inc 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by AMEDISYS Inc in conjunction with their 2018 Q1 earnings Read more …
Amedisys  beats by $0.12, beats on revenue
Amedisys (NASDAQ: AMED ): Q1 EPS of $0.79 beats by $0.12 . More news on: AMEDISYS Inc, Earnings news and commentary, Healthcare stocks news, Read more …
Notable earnings after Monday's close
AIV , AMC , AMED , ANDE , ANDV , ANDX , APLE , ATSG , AWR , BHF , BKD , BKI , CARB , CBT , CENT , CRZO , DCP , DHT , DK , DPLO , EGAN , EQC , EVBG , EVHC , EVRI , FN , FRGI , FRPT , GBDC , HTZ , IAG , IFF , IVC , JCOM , KAMN , LBRT , LCI , LMNX , MOS ,…
LHC Group up 7% on new Medicare policy expanding coverage for non-skilled home health services
Thinly traded LHC Group ( LHCG +8.1% ) perks up on light volume on the heels of an announcement from CMS that it has finalized a range of policies aimed at driving down drug costs for Medicare beneficiaries. More news on: LHC Group, AMEDISYS Inc, Healthcare stocks news, Stocks on the m…
Premarket analyst action - healthcare
Synlogic (NASDAQ: SYBX ) initiated with Buy rating and $20 (104% upside) price target at H.C. Wainwright. More news on: Synlogic, Inc., Arbutus Biopharma Corp, Ignyta, Inc., Healthcare stocks news, , Read more …
Amedisys' (AMED) CEO Paul Kusserow on Q4 2017 Results - Earnings Call Transcript
Amedisys, Inc. (AMED) Q4 2017 Earnings Conference Call February 28, 2018 12:00 ET Executives David Castille - Managing Director, Finance Paul Kusserow - President and CEO Scott Ginn - CFO Chris Gerard - COO Dave Kemmerly - General Counsel and SVP, Government Affairs Analys…
AMEDISYS Inc 2017 Q4 - Results - Earnings Call Slides
The following slide deck was published by AMEDISYS Inc in conjunction with their 2017 Q4 earnings Read more …
Amedisys  misses by $0.02, beats on revenue
Amedisys (NASDAQ: AMED ): Q4 EPS of $0.56 misses by $0.02 . Revenue of $404.23M (+10.7% Y/Y) beats by $9.61M . Press Release More news on: AMEDISYS Inc, Earnings news and commentary, Healthcare stocks news,
Amedisys Inc (AMED)